Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3).

Timothy S BaileyJasmanda Wu Fang Liz ZhouRishab A GuptaArjun A MenonPaulos BerhanuJukka WesterbackaJohn Van VleetLawrence Blonde

Published in: Diabetes, obesity & metabolism (2019)

Among older adults with T2D, switching to Gla-300 versus Gla-100/IDet was associated with greater/similar improvements in glycaemic control, and generally less hypoglycaemia.

Keyphrases

type diabetes
glycemic control
community dwelling
physical activity
middle aged
insulin resistance
adipose tissue
metabolic syndrome